Drug & intervention

ibrutinib

RxCUI 1442981

Clinical trials9
Recruiting0
Related conditions20
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

9 shown
Ibrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell TransplantNCT06271616 · 2024-12-13
TERMINATED
Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host DiseaseNCT04294641 · 2021-05-10
COMPLETED
Study of Ibrutinib Followed by Ibrutinib in Combination With Nivolumab in Non-Small Cell Lung Cancer (NSCLC)NCT02950038 · 2016-12-01
WITHDRAWN
Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Duvortuxizumab (JNJ-64052781) Plus Ibrutinib in LymphomaNCT02743546 · 2016-07-20
WITHDRAWN
Ibrutinib as Neoadjuvant Therapy in Localized Prostate CancerNCT02643667 · 2016-07-01
COMPLETED
A Phase I/II Study of Ibrutinib in Previously Treated Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung CancerNCT02321540 · 2015-03-31
COMPLETED
A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid TumorsNCT02403271 · 2015-03-01
COMPLETED
A Long-term Extension Study of PCI-32765 (Ibrutinib)NCT01804686 · 2013-09-09
ACTIVE_NOT_RECRUITING
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaNCT01578707 · 2012-06-01
COMPLETED

Conditions being studied

Chronic Graft Versus Host Disease2Small Lymphocytic Lymphoma2Breast Cancer1Chronic GVHD1Chronic Lymphocytic Leukemia1Diffuse Large B-cell Lymphoma1Follicular Lymphoma1Hematopoietic and Lymphatic System Neoplasm1Leukemia, Lymphocytic, Chronic, B-Cell1Lung Cancer1Lung Cancer, Nonsmall Cell, Stage I1Lymphoma, Follicular1Lymphoma, Large B-Cell, Diffuse1Lymphoma, Mantle-Cell1Mantle Cell Lymphoma1Non-Small Cell Lung Cancer1Pancreatic Cancer1Prostate Cancer1Relapsed or Refractory Chronic Lymphocytic Leukemia1Waldenstrom Macroglobulinemia1

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.